Lenvatinib-induced thyroid abnormalities in unresectable hepatocellular carcinoma
Latest Information Update: 21 Feb 2020
At a glance
- Drugs Lenvatinib (Primary)
- Indications Liver cancer
- Focus Pharmacodynamics
Most Recent Events
- 08 Apr 2019 New trial record